FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Cyprotex PLC

Evotec announces its intent to acquire Cyprotex PLC

27-Oct-2016 - Evotec AG announced that it has made an offer to acquire Cyprotex PLC, a specialist pre-clinical contract research organisation in ADME-Tox and DMPK. Cyprotex serves the industry's increasing requirement for earlier drug screening, regulatory requirements and reducing the reliance on animal ...

acquisitions drug discovery

Sygnature Discovery and Cyprotex Extend Successful Strategic Alliance for a Further Two Years

20-Dec-2011 - Sygnature Discovery Ltd. and Cyprotex Discovery Ltd announced they have entered into an extension of their highly successful strategic alliance for a further 2 years. Under the terms of the extension of the agreement, Sygnature and Cyprotex will expand their collaborative sales and marketing ...

drug discovery

Cyprotex Launches Mechanism-Based Inhibition of Cytochrome P450 Screening Service

10-Jul-2006 - Cyprotex announces the launch of its new screening service, designed to help drug discovery teams identify compounds which are mechanism-based inhibitors of Cytochrome P450 (CYP450). The inhibition of human CYP450s is one of the most common mechanisms which can lead to drug-drug interactions. ...

assays drug discovery inhibitors +4

Cyprotex receives dual boost for research development

31-Oct-2005 - Cyprotex PLC, a drug discovery technology and information company, announced it has received peer-approved publication of its "virtual human and rat" system, known as Cloe PK(R). The details of extensive validation results for Cloe PK(R) showing how the technology can estimate blood levels of new ...

biotechnology collaborations metabolism +1